Sapporo Clinical Laboratory Inc. (TSE:9776) announces a share repurchase program. Under the program, the company will repurchase 22,700 shares, representing 0.67% of its share capital for ¥29.21 million. The company will repurchase its shares at a price of ¥1,287 per share.

The company will repurchase its shares in order to implement a flexible capital policy in response to changes in the business environment. As of May 30, 2022, the company had 3,353,278 shares in issue (excluding treasury stock) and 862,722 shares in treasury.